Events Search and Views Navigation
July 2022
11th Annual Focus on Eye Health National Summit
On July 13-14, 2022, Prevent Blindness will host the 11th annual Focus on Eye Health National Summit as a virtual interactive event. The event will be held over two days via a virtual conference platform that offers simultaneous access to expert presentations; a dedicated exhibitor hall with access to free educational materials, videos, and toolkits; on-demand educational content; and in-platform opportunities for networking and collaboration. The Summit will be available to a global audience at no cost to attendees. The…
Menopause Mindfulness: A Personal Toolkit for Menopause Preparedness
Approximately 1.3 million women in the United States transition into menopause each year. During the menopause transition (perimenopause), the body undergoes hormonal changes, characterized by a significant decrease in estrogen. This change typically begins to occur in a woman’s late 40s or 50s, and can last up to 10 or 20 years. However, some individuals may experience menopause early due to certain medical conditions or surgical procedures. Menopause, itself, is defined as the point in time 12 months after a…
Diverse Voices Virtual Talk: COVID-19 in Women
ORWH’s new quarterly lecture series, titled “Diverse Voices: Intersectionality and the Health of Women,” will amplify research that incorporates an intersectional framework and addresses the breadth of topics relevant to the health of women. The July 28, 2022, session of “Diverse Voices: Intersectionality and the Health of Women” will focus on COVID-19 in women, featuring presentations from Heather Shattuck-Heidorn, Ph.D., of the University of Southern Maine and Stephaun Wallace, Ph.D., M.S., M.O.L., of the Fred Hutchinson Cancer Research Center. REGISTER
August 2022
Menopause Mindfulness: Understanding the Many Paths to Menopause
Approximately 1.3 million women in the United States transition into menopause each year. During the menopause transition (perimenopause), the body undergoes hormonal changes, characterized by a significant decrease in estrogen. This change typically begins to occur in a woman’s late 40s or 50s, and can last up to 10 or 20 years. However, some individuals may experience menopause early due to certain medical conditions or surgical procedures. Menopause, itself, is defined as the point in time 12 months after a…
September 2022
Ovarian Cancer Screening: More than a Pelvic Exam
In the United States, there are more than 100 diagnostic tests and procedures available for detecting diseases and monitoring their progression. Diagnostic tools are also used to guide treatments and evaluate their effectiveness. Some tests are invasive, such as a biopsy or endoscopy; whereas others are noninvasive, such as x-rays and ultrasound imaging procedures. Innovations in diagnostics provide access to health information, helping women make informed decisions about their health care at every stage of their lives. Screening and diagnostic…
Menopause Mindfulness: Living Your Best Work-Life through the Menopause Transition
Event is at 1:00 p.m. EDT (UTC-4:00) Approximately 1.3 million women in the United States transition into menopause each year. During the menopause transition (perimenopause), the body undergoes hormonal changes, characterized by a significant decrease in estrogen. This change typically begins to occur in a woman’s late 40s or 50s, and can last up to 10 or 20 years. However, some individuals may experience menopause early due to certain medical conditions or surgical procedures. Menopause, itself, is defined as the point…
SWHR Policy Advisory Council Meeting
SWHR’s Policy Advisory Council will meet for its quarterly closed-door meeting. The Policy Advisory Council is a forum for industry, nonprofit, and other health care stakeholders to partner with SWHR to support emerging scientific research and public policy that will improve women’s health. Council members will have an opportunity to work collaboratively to develop policy positions, promote research, and create materials designed benefit women’s health. LEARN MORE
WOMEN’S HEALTH INNOVATION SUMMIT 2022
The Women's Health Innovation Summit is accelerating innovation, investment, research and partnerships, to improve the access and quality of healthcare for women worldwide. Now in its fourth year, the Summit is delighted to be reconvening face-to-face in Boston this September for its biggest industry-leading networking event to date. Past annual summits’ have succeeded in addressing and bringing awareness to a wide range of verticals, challenges and unmet needs for women and their health. Building on this, the team will be…
Diverse Voices Virtual Talk: Violence and Women
ORWH’s new quarterly lecture series, titled “Diverse Voices: Intersectionality and the Health of Women,” will amplify research that incorporates an intersectional framework and addresses the breadth of topics relevant to the health of women. The September 29, 2022, session of “Diverse Voices: Intersectionality and the Health of Women” will focus on violence and women, featuring presentations from Natacha DeGenna, Ph.D., of the University of Pittsburgh and Sahnah Lim, Ph.D., M.P.H., M.I.A., of the NYU Grossman School of Medicine. REGISTER
October 2022
Understanding the Tests that Could Save My Breasts
In the United States, there are more than 100 diagnostic tests and procedures available for detecting diseases and monitoring their progression. Diagnostic tools are also used to guide treatments and evaluate their effectiveness. Some tests are invasive, such as a biopsy or endoscopy; whereas others are noninvasive, such as x-rays and ultrasound imaging procedures. Innovations in diagnostics provide access to health information, helping women make informed decisions about their health care at every stage of their lives. Screening and diagnostic…
Goals
- Discuss the impacts of breast cancer on women’s health, including disparities in disease burden and access to care
- Provide an overview of screening guidelines, diagnostic tests, and key considerations for disease management
- Emphasize ways to empower women, improve quality of care, and general wellbeing
Panelists
Oluwadamilola “Lola” Fayanju, MD, MA, MPHS, FACS
Oluwadamilola “Lola” Fayanju, MD, MA, MPHS, FACS
Dr. Fayanju is the Helen O. Dickens Presidential Associate Professor in the Perelman School of Medicine at the University of Pennsylvania and the Chief of Breast Surgery for the University of Pennsylvania Health System. She is also Surgical Director of the Rena Rowan Breast Center in the Abramson Cancer Center, Director of Health Equity Innovation at the Penn Center for Cancer Care Innovation (PC3I), and a Senior Fellow of the Leonard Davis Institute for Health Economics (LDI) at the University of Pennsylvania. She is an academic breast surgical oncologist whose research focuses on redressing health disparities; improving prognostication and management of aggressive breast cancer variants; generating value in oncology, particularly through the collection and application of patient-reported outcomes (PROs); and promoting diversity and inclusion in healthcare and research. She received her undergraduate degree in History and Science and an MA in Comparative Literature from Harvard. She received her MD and a master’s of population health sciences (MPHS) from Washington University in St. Louis, where she also completed her residency in General Surgery. She completed fellowship training in Breast Surgical Oncology at The University of Texas MD Anderson Cancer Center. In 2019, she was recognized by the National Academy of Medicine as an Emerging Leader in Health and Medicine Scholar. Her research is supported by funding from the National Institutes of Health (NIH), and she has published in a variety of journals including Annals of Surgery, Cancer, and JAMA.
Myrlene Jeudy, MD
Myrlene Jeudy, MD
Whether a routine OB/GYN visit or a more complex patient case, Dr. Myrlene Jeudy’s approach is the same: Listen, and allow individuals to be heard. Most of Dr. Jeudy’s time is spent treating people of all ages as a board-certified OB/GYN. Every day and patient is different: she may see a pregnant person, perform an operation, treat periods and menopausal concerns, or help with family planning. Dr. Jeudy returned to VCU Health in 2021 after a brief time in Georgia. In her role as a professor in the VCU Department of Obstetrics and Gynecology, she teaches and trains future OB/GYNs to carry on her work. Dr. Jeudy was first introduced to the field of obstetrics and gynecology in Cameroon, Africa. There, she worked with an OB/GYN at the University Teaching Hospital of Yaoundé. In addition to general obstetrics and gynecology, Dr. Jeudy has specialized training in cancer genetics and breast health, and treats women who are at an elevated risk of breast or ovarian cancer. That includes discovering harmful variants of the BRCA1 and BRCA2 genes, which put women at higher risk of breast and ovarian cancers. For those women who are diagnosed with cancer, she works closely with oncologists and cancer specialists to ease the gynecologic side effects of treatment, including safety of pregnancy, hormonal therapies, chemotherapy or treatment-induced menopause, vaginal dryness, sexual dysfunction, and surgeries.
Sponsor
SWHR’s Value of Diagnostics within Women’s Health series is supported by an educational sponsorship from Roche. SWHR maintains editorial control and independence over educational content.
